GL1X · GenesisL1 explorer

Research workbench

Crystal structure of clade A/E 93TH057 HIV-1 GP120 core in complex with aws-I-169

Analyse Crystal structure of clade A/E 93TH057 HIV-1 GP120 core in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DKR
Type
protein
Length
678 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 GP120 core
Ligands
0LJ, NAG
Pockets
8 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 17% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CHIV-1 GP120 coreprotein33917% helix, 37% strand—

Ligands and binding sites

  • 0LJ · N-[(1R,2R)-2-carbamimidamido-2,3-dihydro-1H-inden-1-yl]-N'-(4-chloro-3-fluorophenyl)ethanediamide · ligand · 2 copies · chains A, C
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 22 copies · chains A, C
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17210.770.8289NAG
2880.640.90230LJ
3730.570.88190LJ
4640.490.8417NAG
5570.440.8321empty

Interfaces

1 interface between chains.

  • A–C · 469 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 22 glycan, 14 disulfide (N-glycosylation, disulfide).

Compared structures

  • 4DKR · Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-169 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.